Skip to main content

VBI Vaccines Inc/BC

VBIVDelisted Sep 6, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0000764195

VBI Vaccines Inc/BC was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jul 31, 2023; 41 institutions reported holding it in 13F filings for Q2 2024, worth $1.79M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in VBI Vaccines Inc/BC as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
−2 vs. Q2 2022
Shares held
98.8M
−3.72M (−3.6%) vs. Q2 2022
Total value
$69.9M
−$12.9M (−15.6%) vs. Q2 2022
New holders
11
30 more added
Sold out
13
50 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VBIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 128 institutions
Q1 2021: 137 institutionsQ2 2021: 134 institutionsQ3 2021: 126 institutionsQ4 2021: 134 institutionsQ1 2022: 131 institutionsQ2 2022: 131 institutionsQ3 2022: 128 institutionsQ4 2022: 115 institutionsQ1 2023: 96 institutionsQ2 2023: 46 institutionsQ3 2023: 37 institutionsQ4 2023: 39 institutionsQ1 2024: 36 institutionsQ2 2024: 41 institutionsQ3 2024: 1 institutionQ4 2024: 2 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $69.9M
Q1 2021: $376.1MQ2 2021: $384.3MQ3 2021: $347.3MQ4 2021: $260.0MQ1 2022: $191.2MQ2 2022: $83.3MQ3 2022: $69.9MQ4 2022: $36.7MQ1 2023: $27.9MQ2 2023: $7.06MQ3 2023: $1.90MQ4 2023: $1.71MQ1 2024: $1.61MQ2 2024: $1.79MQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VBIV and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20242$0
Q3 20241$0
Q2 202441$1.79M
Q1 202436$1.61M
Q4 202339$1.71M
Q3 202337$1.90M
Q2 202346$7.06M
Q1 202396$27.9M
Q4 2022115$36.7M
Q3 2022128$69.9M
Q2 2022131$83.3M
Q1 2022131$191.2M
Q4 2021134$260.0M
Q3 2021126$347.3M
Q2 2021134$384.3M
Q1 2021137$376.1M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding VBI Vaccines Inc/BC; share changes are against Q2 2022.

Institutions holding VBIV in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Wealth Alliance Advisory Group, LLC193,000$136.0K0.06%+181,000+1,508.3%Added
Two Sigma Advisers, LP204,500$144.0K0.00%−180,300−46.9%Reduced
Deutsche Bank AG210,689$149.0K0.00%−693−0.3%Reduced
Susquehanna International Group, LLP219,069$155.0K0.00%−110,372−33.5%Reduced
Price T Rowe Associates Inc231,306$165.0K0.00%+43,972+23.5%Added
California State Teachers Retirement System242,744$171.0K0.00%−4,653−1.9%Reduced
Rhumbline Advisers280,001$198.0K0.00%+14,118+5.3%Added
Grimes & Company, Inc.288,901$204.0K0.01%+3,479+1.2%Added
Raymond James & Associates292,199$206.0K0.00%−139,299−32.3%Reduced
Goldman Sachs Group Inc301,746$213.0K0.00%−907,761−75.1%Reduced
Bank of America Corp388,951$273.0K0.00%+116,639+42.8%Added
Swiss National Bank456,200$322.0K0.00%00.0%Unchanged
Captrust Financial Advisors601,830$425.0K0.00%+601,800+2,006,000.0%Added
Gsa Capital Partners LLP624,438$441.0K0.06%−42,621−6.4%Reduced
Nuveen Asset Management, LLC719,134$508.0K0.00%−12,075−1.7%Reduced
Bank of New York Mellon Corp728,351$514.0K0.00%+63,271+9.5%Added
Invesco Ltd.871,479$615.0K0.00%+193,647+28.6%Added
Renaissance Technologies LLC915,990$647.0K0.00%+126,490+16.0%Added
Millennium Management LLC1,119,735$790.0K0.00%−661,017−37.1%Reduced
Charles Schwab Investment Management Inc1,429,085$1.01M0.00%−42,372−2.9%Reduced
Northern Trust Corp1,807,937$1.28M0.00%−53,629−2.9%Reduced
General American Investors Co Inc1,877,497$1.32M0.14%00.0%Unchanged
Vanguard Group Inc2,640,727$1.86M0.00%−1,752,127−39.9%Reduced
Cambridge Investment Research Advisors, Inc.3,132,545$2.21M0.01%+899,395+40.3%Added
Geode Capital Management, LLC3,896,177$2.75M0.00%−218,031−5.3%Reduced
State Street Corp4,615,290$3.26M0.00%+633,515+15.9%Added
BlackRock Inc.13,456,431$9.50M0.00%−251,271−1.8%Reduced
Perceptive Advisors LLC52,335,002$37.2M1.08%00.0%Unchanged
HSBC Holdings PLC0$00.00%−127,718−100.0%Sold out
Two Sigma Investments, LP0$00.00%−106,623−100.0%Sold out
Virtu Financial LLC0$00.00%−81,649−100.0%Sold out
Centiva Capital, LP0$00.00%−55,252−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−54,623−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−51,966−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−21,742−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−13,145−100.0%Sold out
MetLife Investment Management0$00.00%−12,431−100.0%Sold out
Strategic Blueprint, LLC0$00.00%−12,250−100.0%Sold out
WMS Partners, LLC0$00.00%−10,000−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−5,900−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−51−100.0%Sold out
Frontier Wealth Management LLC––––Not filed